Theodore H. Stanley, Director at Insys Therapeutics, Inc. (INSY), bought 400 shares at $73.80 ($30K) on 2014-03-06, disclosed to the SEC on 2014-03-06.
Open-market purchase of $30k INSY by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.99 | 100 | $8K | 25.4% |
| 2 | $77.60 | 100 | $8K | 25.6% |
| 3 | $73.80 | 100 | $7K | 24.3% |
| 4 | $74.73 | 100 | $7K | 24.7% |
| Total | $75.78 avg | 400 | $30K | 100% |
| Filing → |
| INSY | SELL | 2016-03-04 | $362K | — | Filing → |
| INSY | SELL | 2015-09-14 | $148K | — | Filing → |
| INSY | SELL | 2015-03-10 | $198K | — | Filing → |